▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2225 by analyst upside · 2026-06-27
ORGO
Organogenesis Holdings Inc.
Healthcare · Market Cap $313M · P/E 0x
ANALYST PRICE TARGET
+23.5%
implied upside to consensus target
Current Price $2.43
Consensus Target $3.0
Bull Target $3.0
Bear Target $3.0
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $2.04
52-Week High $7.08
YTD Return -47.6%
FUNDAMENTALS
Market Cap $313M
P/E Ratio (TTM) N/A
Forward P/E -8.8x
EPS (TTM) $-0.12
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $515M
Profit Margin 0.5%
52-WEEK RANGE
52-Week Low $2.04
52-Week High $7.08
Current Price $2.43
Bear Target $3.0
Bull Target $3.0
● Now $2.43 ● Target $3.0
TRADING DATA
Avg Volume 1.5M
YTD Return -47.6%
Analyst Count 1
Consensus Buy
Upside to Target +23.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Organogenesis Holdings Inc. (ORGO) is currently trading at $2.43 with a Wall Street consensus price target of $3.0, implying potential upside of 23.5% over the next 12 months. 1 analysts currently cover ORGO, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $3.0, while the most cautious has a target of $3.0.

ORGO operates in the Healthcare sector with a market capitalisation of $313M. The stock is down 47.6% year-to-date and is currently trading near the lower end of its 52-week range of $2.04 – $7.08.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

AUNA +35.6%
Auna SA
$381M · P/E 18.4x · Buy
QTTB +8.2%
Q32 Bio Inc.
$223M · P/E 4.7x · Buy
SPOK +31.5%
Spok Holdings, Inc.
$222M · P/E 18.1x · Hold
ELMD -2.7%
Electromed, Inc.
$343M · P/E 35.4x · Buy
EMBC +14.6%
Embecta Corp.
$207M · P/E 1.8x · Underperform

RECENT ANALYST CALLS

Upgrade/downgrade history for ORGO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Truist Securities ● Initiated
Hold 2026-05-28 Building track record
BTIG reit
Buy → Buy 2026-03-26 38% win rate (8 calls)
BTIG — Reiterated
Buy → Buy 2026-02-27 38% win rate (8 calls)
BTIG reit
Buy → Buy 2025-12-26 38% win rate (8 calls)
BTIG reit
Buy → Buy 2025-12-15 38% win rate (8 calls)
BTIG — Reiterated
Buy → Buy 2025-11-20 38% win rate (8 calls)
BTIG reit
Buy → Buy 2025-09-26 38% win rate (8 calls)
Cantor Fitzgerald — Reiterated
Overweight → Overweight 2025-08-08 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →